Thus, in this study, we have analyzed different groups of cytokines, adipokines, ACh neurotransmitter, and B-cell differentiation molecules to better understand their networks in naive RR-MS patients compared to IFN-β-treated MS patients and HC. The gene discussed is IFNB1; the disease is myeloid sarcoma.